… The demand for cannabis in the treatment of pain precedes formal approval by the United
States Food and Drug Administration. Observational studies have shown that states with …

… may have cognitive deficits that might make adhering to treatment, following medical advice,
… the effects of cannabis in PwMS with neuropathic and spasticity-related pain and spasms (…

… (THC) and cannabidiol (CBD), is approved to treat adult patients … antispasticity medication
(Electronic Medicines Compendium, … multiple sclerosis: a systematic review and meta-analysis …

… cannabis and medicinal cannabis for the treatment of non-oncologic chronic pain, such as
neuropathic pain, multiple sclerosis-related … a systematic review and meta-analysis to assess …

… found only weak evidence that cannabis alleviates neuropathic pain, and no evidence …
meta-analysis specifically examining the use of cannabis to treat non-cancer related chronic pain …

… Cannabinoid effectiveness on multiple sclerosis related pain compared with placebo was
observed in the CAMS study [41] and in the MUSEC trial, focused on stiffness management [42]…

… on the pharmacological treatment of neuropathic pain: 2010 … the treatment of trigeminal
neuralgia associated with multiple … rTMS for suppressing neuropathic pain: a meta-analysis. J …

… to the meta-analysis due to the wide assortment of pain … in neuropathic pain and multiple
sclerosis-related spasticity. As cannabinoids are effective in the treatment of neuropathic pain, …

… According to the meta-analysis of different types of fatigue … for a while, forgetting about the
pain and limitations and simply … Due to the negative influence of high temperature on nerve …

… -tetrahydrocannabinol (THC) and cannabidiol (CBD) administered … However, according to a
recent review and meta-analysis, … In this study, pain was more common in RRMS patients but …